VivoSim Labs (VIVS) FCF Margin Growth (1y) (2012 - 2026)
Powered by 
Analysis
VivoSim Labs (VIVS) FCF Margin Growth (1y) (2012 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | 97.00 |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | -408.00 |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | 693.00 |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | -160.00 |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | 92.00 |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | -12,969.00 |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | -629.00 |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | 3,881.00 |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | -732,913.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -732,913.00 |
| Mar 31, 2026 | -157,730.00 |
| Dec 31, 2025 | -127,276.00 |
| Sep 30, 2025 | 35,714.00 |
| Jun 30, 2025 | -299,993.00 |
| Mar 31, 2025 | 522,015.00 |
| Dec 31, 2024 | 6.29 Mn |
| Jun 30, 2024 | -54,738.00 |
| Mar 31, 2024 | -618,874.00 |
| Dec 31, 2023 | -6.81 Mn |
| Mar 31, 2023 | -291,534.00 |
| Dec 31, 2019 | 31,502.00 |
| Sep 30, 2019 | 4,060.00 |
| Jun 30, 2019 | 13,069.00 |
| Mar 31, 2019 | -23,270.00 |
| Dec 31, 2018 | 5,118.00 |
| Sep 30, 2018 | -258.00 |
| Jun 30, 2018 | 5,801.00 |
| Mar 31, 2018 | 40,589.00 |
| Dec 31, 2017 | 10,358.00 |